REGN1500 250 mg SC/15 mg/kg IV/450 mg SC
R1500-CL-1331
Phase 2 small_molecule completed
Quick answer
REGN1500 250 mg SC/15 mg/kg IV/450 mg SC for Homozygous Familial Hypercholesterolemia is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Homozygous Familial Hypercholesterolemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed